BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/4/2024 3:55:02 PM | Browse: 57 | Download: 391
 |
Received |
|
2024-03-10 12:28 |
|
Peer-Review Started |
|
2024-03-10 12:28 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-04-16 20:56 |
|
Revised |
|
2024-04-24 11:44 |
|
Second Decision |
|
2024-05-06 02:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-05-06 10:19 |
|
Articles in Press |
|
2024-05-06 10:19 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-27 15:44 |
|
Publish the Manuscript Online |
|
2024-06-04 15:55 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Otorhinolaryngology |
| Manuscript Type |
Case Report |
| Article Title |
Treatment of primary nasal tuberculosis with anti-tumor necrosis factor immunotherapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yong-Cai Liu, Min-Li Zhou, Ke-Jia Cheng, Shui-Hong Zhou and Xue Wen |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Depaetment of Health of Zhejiang Province |
2019-KY1-001-138 |
| Zhejiang Provincial Natural Science Foundatio |
LTGY24H160016 |
|
| Corresponding Author |
Ke-Jia Cheng, MD, Chief Doctor, Department of Otolaryngology, The First Affiliated Hospital, College of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China. 1505026@zju.edu.cn |
| Key Words |
Primary nasal tuberculosis; Anti-tumor necrosis factor immunotherapy; Granulomatous inflammation; Psoriatic arthritis; acid-fast bacilli; Case report |
| Core Tip |
Primary nasal tuberculosis is a rare form of extrapulmonary tuberculosis (TB), particularly in patients receiving anti-tumor necrosis factor immunotherapy. The nasal cavity is most commonly involved; most infections involve the nasal septum and/or the inferior turbinate. We should remain vigilant for primary nasal TB in patients treated with tumor necrosis factor antagonists if the nasal mucosa of the nasal septum or the inferior turbinate demonstrates thickening or crusting, particularly when pathological findings suggest granulomatous inflammation. For suspected cases, repeated biopsies may enhance the identification of acid-fast bacilli. |
| Publish Date |
2024-06-04 15:55 |
| Citation |
<p>Liu YC, Zhou ML, Cheng KJ, Zhou SH, Wen X. Treatment of primary nasal tuberculosis with anti-tumor necrosis factor immunotherapy: A case report. <i>World J Clin Cases</i> 2024; 12(17): 3271-3276</p> |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i17/3271.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i17.3271 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
